Fine Organic Industries Ltd Q4 FY25 Results & Concall Highlights: Revenue, Margins & Order Book
Published 8 Aug 2026 | Chemicals & Petrochemicals | Market Cap: ₹15.1K Cr
Domestic demand is growing strongly at around 8-10% CAGR, higher than the global average of 5-6%. Fine Organic Industries projects growth driven by new capacities at JNPA SEZ facility (INR 700-750 crores capex over 18-24 months) and upcoming U.S.
From Fine Organic Industries Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.
Price
₹5,160
Market Cap
₹15.1K Cr
P/E Ratio
37.1
How does Fine Organic Industries Ltd rank in Chemicals & Petrochemicals?
Compare Fine Organic Industries Ltd against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.
Fine Organic Industries Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹625 Cr, net profit ₹117 Cr.
Full financials →📊 Revenue & Sales Performance
- →Domestic demand is growing strongly at around 8-10% CAGR, higher than the global average of 5-6%.
- →Current plants (except Patalganga) are running near full capacity; growth would mainly come from ramping up Patalganga plant and new SEZ plant.
- →The SEZ facility (JNPTA) primarily targets exports and will free capacity at existing plants for domestic growth; expected commissioning in 18-24 months.
- →U.S. manufacturing facility planned to strengthen local market presence; initial capacity conservative but expected rapid fill due to existing customer base.
- →Overall volume growth expected to be moderate (around 5-6% CAGR) until new capacities (JNPTA, U.S.) come online.
- →Post expansion (2-3 years), significant growth expected but exact numbers not disclosed; confident about scaling in U.S. and international markets.
- →No business currently lost due to capacity constraints; new customer additions limited until expansions complete.
📈 Profitability & Margins
- →Fine Organic Industries projects growth driven by new capacities at JNPA SEZ facility (INR 700-750 crores capex over 18-24 months) and upcoming U.S. manufacturing plant.
- →U.S. facility expected to boost market share by enabling local production, reducing lead times, and meeting regulatory needs.
- →Existing plants’ capacities currently near full utilization; growth until new capacities come online expected to be modest (~5-6% volume CAGR).
- →Post-expansion, significant capacity increase anticipated, though exact earnings or EPS guidance is not provided.
- →Company expects capacity ramp-up to unlock domestic and export market growth opportunities.
- →Management confident of growth but refrains from specific numeric forecasts.
- →Ongoing focus on operational agility and cost management to protect margins despite raw material and logistic cost pressures.
- →Potential M&A activity planned as part of growth strategy, indicating further avenues for earnings expansion.
🏗️ Capital Expenditure Plans
- →INR 750 crores capex planned for new manufacturing facility at JNPA SEZ, Maharashtra, to be completed in 18-24 months (Phased production start) (Pages 3-5).
- →Incorporation of a new wholly owned manufacturing entity in the U.S. underway to enhance local presence and serve U.S. customers better; initial capacity will be conservative with phase-wise expansions expected (Pages 4-7).
- →Wholly owned subsidiary being set up in UAE for better supply chain efficiency in Middle East (Page 4).
- →Capex in FY '25 was around INR 125 crores including maintenance and R&D, with some capacity creation (Pages 9-11).
- →Initial equity infusion of INR 45 crores related to U.S. plant land and early expenses; full Phase 1 capex yet to be announced (Page 13).
- →Expansion financed through a mix of internal accruals and debt; cash reserves (~INR 1,200 crores) planned to fund SEZ and U.S. expansions and possible M&A (Pages 9-12).
💰 Fundraising & Capital Structure
- →Fine Organic Industries is open to raising debt to fund their expansion plans.
- →The company plans to finance upcoming projects through a mix of internal accruals and debt financing.
- →There is mention of raising equity initially for the US plant-related expenditures, but the full capex details and fundraising specifics will be announced later.
- →No explicit mention of any planned equity fundraise at this time.
- →The company intends to keep some cash reserve to explore potential M&A opportunities, indicating a strategic use of funds.
- →Overall, funding for expansions (including SEZ and US facilities) will involve a combination of internal funds and debt, with equity infusion as needed for initial expenses, but detailed plans will be disclosed at an appropriate time.
📋 Order Book & Pipeline
Key Metrics
Frequently Asked Questions
What were Fine Organic Industries Ltd Q4 FY25 results?
Domestic demand is growing strongly at around 8-10% CAGR, higher than the global average of 5-6%. Fine Organic Industries projects growth driven by new capacities at JNPA SEZ facility (INR 700-750 crores capex over 18-24 months) and upcoming U.S.
What is Fine Organic Industries Ltd share price analysis?
Fine Organic Industries Ltd currently shows a neutral. The stock trades at a P/E of 37.1 with a market cap of ₹15,147 Cr. Investors should review the full earnings analysis for detailed insights.
Is Fine Organic Industries Ltd planning capital expenditure?
INR 750 crores capex planned for new manufacturing facility at JNPA SEZ, Maharashtra, to be completed in 18-24 months (Phased production start) (Pages 3-5). - Incorporation of a new wholly owned manufacturing entity in the U.S.
Keep Fine Organic Industries Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.